These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37564471)

  • 1. Study of Three Potential Diagnostic Biomarkers in Nasopharyngeal Carcinoma Samples from Guilan, North of Iran.
    Moghaddam SJK; Roushandeh AM; Roudkenar MH; Nemati S; Najafi-Ghalehlou N; Pakzad T; Hamidi M
    Int Arch Otorhinolaryngol; 2023 Jul; 27(3):e461-e470. PubMed ID: 37564471
    [No Abstract]   [Full Text] [Related]  

  • 2. The Clinical Significance of IGF-1R and Relationship with Epstein-Barr Virus Markers: LMP1 and EBERs in Tunisian Patients with Nasopharyngeal Carcinoma.
    Baizig NM; Wided BA; Amine OE; Gritli S; ElMay M
    Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):1011-1019. PubMed ID: 32468823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma.
    Chew MM; Gan SY; Khoo AS; Tan EL
    BMC Cancer; 2010 Oct; 10():574. PubMed ID: 20964870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV‑LMP1 is involved in vasculogenic mimicry formation via VEGFA/VEGFR1 signaling in nasopharyngeal carcinoma.
    Xu S; Bai J; Zhuan Z; Li B; Zhang Z; Wu X; Luo X; Yang L
    Oncol Rep; 2018 Jul; 40(1):377-384. PubMed ID: 29749553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia.
    See HS; Yap YY; Yip WK; Seow HF
    World J Surg Oncol; 2008 Feb; 6():18. PubMed ID: 18275617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.
    Yu PH; Chou SF; Chen CL; Hung H; Lai CY; Yang PM; Jeng YM; Liaw SF; Kuo HH; Hsu HC; Chen JY; Wang WB
    PLoS One; 2013; 8(12):e82254. PubMed ID: 24340011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
    Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
    Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
    Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
    Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of Wnt5a and LMP1 in the nasopharyngeal carcinogenesis by high-throughput tissue microarray technology].
    Xu L; Zheng J; Li J; Shi L; Fan S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 37(9):865-70. PubMed ID: 23000758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of latent membrane protein 1 (LMP1) and p53 in nasopharyngeal carcinoma: Moroccan experience.
    Tabyaoui I; Serhier Z; Sahraoui S; Sayd S; Cadi R; Bennani OM; Benider A; Zamiati S; Tahiri JN
    Afr Health Sci; 2013 Sep; 13(3):710-7. PubMed ID: 24250311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of lymphangiogenesis through vascular endothelial growth factor-C/vascular endothelial growth factor receptor 3 axis and its correlation with lymph node metastasis in nasopharyngeal carcinoma.
    Wakisaka N; Hirota K; Kondo S; Sawada-Kitamura S; Endo K; Murono S; Yoshizaki T
    Oral Oncol; 2012 Aug; 48(8):703-8. PubMed ID: 22366442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
    Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
    Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma.
    Wang Z; Xie J; Yan M; Wang J; Wang X; Zhang J; Zhang Y; Li P; Lei X; Huang Q; Lin S; Guo X; Liu Q
    Oncotarget; 2016 May; 7(18):26765-79. PubMed ID: 27049918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD47 Overexpression Is Associated with Epstein-Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma.
    Wang ZH; Pei XF; Zhu ZQ; Lin Z; Mao YY; Xu XL; Luo YL; Zhang L; Peng PJ
    Onco Targets Ther; 2020; 13():3325-3334. PubMed ID: 32368091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human Fab antibody fragments specific to LMP1 (HLEAFab) in nasopharyngeal carcinoma for potential molecular diagnosis and therapeutic applications.
    Zhang D; Mao Y; Xiong L; Cao Q; Zhu J; Chen R
    Oncol Lett; 2013 May; 5(5):1694-1698. PubMed ID: 23760364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway.
    Li SS; Yang S; Wang S; Yang XM; Tang QL; Wang SH
    Oncol Rep; 2011 Dec; 26(6):1573-9. PubMed ID: 21850380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of Epstein-Barr virus-encoded latent membrane protein-1 by arsenic trioxide in nasopharyngeal carcinoma cells.
    Du C; Wen B; Li D; Lin Y; Zheng Y; Peng X; Hong C; Chen J; Lin W; Hong X; Xie L; Wu M
    Tumori; 2006; 92(2):140-8. PubMed ID: 16724694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells.
    Murono S; Inoue H; Tanabe T; Joab I; Yoshizaki T; Furukawa M; Pagano JS
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6905-10. PubMed ID: 11381123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study.
    Kontos CK; Fendri A; Khabir A; Mokdad-Gargouri R; Scorilas A
    BMC Cancer; 2013 Jun; 13():293. PubMed ID: 23777485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma.
    Yuan Q; Chen BH; Huang DJ; Zhang R
    Braz J Med Biol Res; 2023; 56():e12638. PubMed ID: 37493769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.